A role for the renin-angiotensin system in hematopoiesis

Haematologica

Volumn 94, Issue 6, 2009, Pages 745-747

  Park, Tea Soon ^a   Zambidis, Elias T ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; BRADYKININ; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; IRBESARTAN; LISINOPRIL; LOSARTAN; OLMESARTAN; TELMISARTAN; VALSARTAN; ZOFENOPRIL;

ANEMIA; BLOOD PRESSURE REGULATION; BONE MARROW APLASIA; BONE MARROW TRANSPLANTATION; CARDIOVASCULAR DISEASE; CELL MIGRATION; CELL PROLIFERATION; CONGESTIVE HEART FAILURE; DRUG EFFECT; DRUG MEGADOSE; EDITORIAL; EMBRYONIC STEM CELL; ERYTHROCYTE LEVEL; ERYTHROCYTOSIS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERKALEMIA; KIDNEY DISEASE; LEUKOPENIA; NONHUMAN; POLYCYTHEMIA VERA; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIDE EFFECT; STROKE;

ANGIOTENSIN I; ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; CORD BLOOD STEM CELL TRANSPLANTATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKOCYTES, MONONUCLEAR; MICE; PEPTIDE FRAGMENTS; RENIN-ANGIOTENSIN SYSTEM; TRANSPLANTATION, HETEROLOGOUS;

EID: 66749168189     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.006965     Document Type: Editorial

References (30)

1. Tigerstedt R, Bergman PG, Niere und Kreislauf. Scandinav Arch J Physiol 1898;8:223.
2. Bernstein KE, Martin BM, Bernstein EA, Linton J, Striker L, Striker G. The isolation of angiotensinconverting enzyme cDNA. J Biol Chem 1988;263:11021-11024
3. Ferrario CM. Does angiotensin-(1-7) contribute to cardiac adaptation and preservation of endothelial function in heart failure? Circulation 2002;105:1523-1525
4. Heringer-Walther S, Eckert K, Schumacher S-M, Uharek L, Wulf-Goldenberg A, Gembardt F, et al. Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo. Haematologica 2009;94:857-860
5. Deshayes F, Nahmias C. Angiotensin receptors: a new role in cancer? Trends Endocrinol Metab 2005;16:293-299
6. Grady EF, Sechi LA, Griffin CA, Schambelan M, Kalinyak JE. Expression of AT2 receptors in the developing rat fetus. J Clin Invest 1991;88:921-933
7. Akishita M, Ito M, Lehtonen JY, Daviet L, Dzau VJ, Horiuchi M. Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth. J Clin Invest 1999;103:63-71. (Pubitemid 29031164)
8. Jokubaitis VJ, Sinka L, Driessen R, Whitty G, Haylock DN, Bertoncello I, et al. Angiotensinconverting enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal, and adult hematopoietic tissues. Blood 2008;111:4055-4063
9. Studer A, Vetter W. Reversible leucopenia associated with angiotensin-converting-enzyme inhibitor MK 421. Lancet 1982;1:458. (Pubitemid 12163025)
10. Griffing GT, Melby JC. Enalapril (MK-421) and the white cell count and haematocrit. Lancet 1982;1:1361.
11. Marubayashi S, Yamamoto H, Shibata S, Fudaba Y, Miyata Y, Fukuma K, et al. Effect of the angiotensin-converting enzyme inhibitor enalapril on post-transplant erythrocytosis. Hiroshima J Med Sci 1998;47:121-124 (Pubitemid 28517091)
12. Mrug M, Stopka T, Julian BA, Prchal JF, Prchal JT. Angiotensin II stimulates proliferation of normal early erythroid progenitors. J Clin Invest 1997;100:2310-2314 (Pubitemid 27500154)
13. Rodgers KE, Xiong S, Steer R, di Zerega GS. Effect of angiotensin II on hematopoietic progenitor cell proliferation. Stem Cells 2000;18:287-294 (Pubitemid 30602276)
14. Goker H, Haznedaroglu IC, Beyazit Y, Aksu S, Tuncer S, Misirlioglu M, et al. Local umbilical cord blood reninangiotensin system. Ann Hematol 2005;84:277-281 (Pubitemid 41166820)
15. Haznedaroglu IC, Tuncer S, Gursoy M. A local renin-angiotensin system in the bone marrow. Med Hypotheses 1996;46:507-510 (Pubitemid 26184769)
16. Haznedaroglu IC, Ozturk MA. Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system. Int J Biochem Cell Biol 2003;35:867-880 (Pubitemid 36379328)
17. Kato H, Ishida J, Imagawa S, Saito T, Suzuki N, Matsuoka T, et al. Enhanced erythropoiesis mediated by activation of the renin-angiotensin system via angiotensin II type 1a receptor. FASEB J 2005;19:2023-2025 (Pubitemid 41759752)
18. Li J, Volkov L, Comte L, Herve P, Praloran V, Charbord P. Production and consumption of the tetrapeptide AcSDKP, a negative regulator of hematopoietic stem cells, by hematopoietic microenvironmental cells. Exp Hematol 1997;25:140-146 (Pubitemid 27101328)
19. Gaudron S, Grillon C, Thierry J, Riches A, Wierenga PK, Wdzieczak-Bakala J. In vitro effect of acetyl-N-Ser-Asp- Lys-Pro (AcSDKP) analogs resistant to angiotensin I-converting enzyme on hematopoietic stem cell and progenitor cell proliferation. Stem Cells 1999;17:100-106
20. Aksu S, Beyazit Y, Haznedaroglu IC, Canpinar H, Kekilli M, Uner A, et al. Over-expression of angiotensin-converting enzyme (CD 143) on leukemic blasts as a clue for the activated local bone marrow RAS in AML. Leuk Lymphoma 2006;47:891-896 (Pubitemid 43840646)
21. Zambidis ET, Park TS, Yu W, Tam A, Levine M, Yuan X, et al. Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells. Blood 2008;112:3601-3614
22. Rousseau-Plasse A, Wdzieczak-Bakala J, Lenfant M, Ezan E, Genet R, Robinson S, et al. Lisinopril, an angiotensin I-converting enzyme inhibitor, prevents entry of murine hematopoietic stem cells into the cell cycle after irradiation in vivo. Exp Hematol 1998;26:1074-1079 (Pubitemid 28477775)
23. Shen XZ, Xiao HD, Li P, Billet S, Lin CX, Fuchs S, et al. Tissue specific expression of angiotensin converting enzyme: a new way to study an old friend. Int Immunopharmacol 2008;8:171-176
24. Cole J, Ertoy D, Lin H, Sutliff RL, Ezan E, Guyene TT, et al. Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin- converting enzyme-deficient mice. J Clin Invest 2000;106:1391-1398
25. Xiao HD, Fuchs S, Frenzel K, Teng L, Li P, Shen XZ, et al. The use of knockout mouse technology to achieve tissue selective expression of angiotensin converting enzyme. J Mol Cell Cardiol 2004;36:781-789 (Pubitemid 38639762)
26. Savary K, Michaud A, Favier J, Larger E, Corvol P, Gasc JM. Role of the renin-angiotensin system in primitive erythropoiesis in the chick embryo. Blood 2005;105:103-110 (Pubitemid 40053070)
27. Schutz S, Le Moullec JM, Corvol P, Gasc JM. Early expression of all the components of the reninangiotensin- system in human development. Am J Pathol 1996;149:2067-2079 (Pubitemid 26415223)
28. Hubert C, Savary K, Gasc JM, Corvol P. The hematopoietic system: a new niche for the reninangiotensin system. Nat Clin Pract Cardiovasc Med 2006;3:80-85 (Pubitemid 43203376)
29. Cohn RD, van Erp C, Habashi JP, Soleimani AA, Klein EC, Lisi MT, et al. Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat med 2007;13:204-210 (Pubitemid 46245764)
30. Grammatopoulos TN, Ahmadi F, Jones SM, Fariss MW, Weyhenmeyer JA, Zawada WM. Angiotensin II protects cultured midbrain dopaminergic neurons against rotenone-induced cell death. Brain res 2005;1045:64-71. (Pubitemid 40725221)